JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Macchiarini, P
Right arrow Articles by Dartevelle, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Macchiarini, P
Right arrow Articles by Dartevelle, P

The Journal of Thoracic and Cardiovascular Surgery, Vol 116, 831-843, Copyright © 1998 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

NOTE: Fulltext is available only in pdf format

Evidence of human non-alpha-galactosyl antibodies involved in the hyperacute rejection of pig lungs and their removal by pig organ perfusion

P Macchiarini, R Oriol, A Azimzadeh, V de Montpreville, R Rieben, N Bovin, M Mazmanian and P Dartevelle
Department of Thoracic and Vascular Surgery, Hopital Marie-Lannelongue, Le Plessis Robinson, Paris-Sud University, France.

BACKGROUND: Human natural xenoantibodies represent a major hurdle to the clinical application of pig lungs in transplantation by initiating hyperacute rejection within minutes to hours. OBJECTIVE: The object was to compare pig organ perfusion and specific depletion of anti-alpha- galactosyl xenoantibodies for prevention of hyperacute rejection in the pig to human lung combination. METHODS: Large White pig (20-25 kg) left lungs were removed and continuously ventilated and reperfused ex vivo either with (1) whole human blood previously perfused in situ through pig right lung (group I), liver (group II), or spleen (group III) or with (2) human plasma in vitro immunoabsorbed on columns containing alpha-galactosyl disaccharide (Gal-alpha-(1-3)Gal-beta-(CH2)3NH2; B disaccharide) (group IV). Each study group included 6 animals. RESULTS: The in situ and in vitro preperfusions depleted anti-alpha-galactosyl xenoantibodies and all in situ perfused pig organs showed histologic signs of hyperacute rejection. After the ex vivo reperfusion, group I xenografts had a significantly (P < .001) longer functional and histologic survival than did xenografts in groups II, III, and IV. Human blood reperfusing group I xenografts had a significantly (P < 0.05) lower (1) decline of clotting factors and total circulating immunoglobulins, (2) total and membrane attack complex (C5b,6,7,8,9) complement activation, and (3) hemolysis. By Western blot analysis, the in situ lung preperfusion removed antibodies against non-alpha- galactosyl proteins of low molecular weight that were not eliminated by the alpha-galactosyl column. CONCLUSIONS: Results demonstrate that specific depletion of anti-alpha-galactosyl antibodies alone incompletely protects pig lungs from hyperacute rejection. It is speculated that the more complete prevention of this rejection afforded by pig lung preperfusion relates to the removal of other, non-alpha- galactosyl antibodies.


This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
S. Pfeiffer, G. L. Zorn III, S. Kelishadi, R. Oriol, P. Wolf, R. N. Pierson III, and A. M. Azimzadeh
Role of anti-Gal{alpha}1,3Gal and anti-platelet antibodies in hyperacute rejection of pig lung by human blood
Ann. Thorac. Surg., November 1, 2001; 72(5): 1681 - 1690.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
C. L. Lau, W. C. Daggett, M. F. Yeatman, P. Chai, S. S. Lin, A. J. Lodge, E. P. Chen, L. E. Diamond, G. W. Byrne, J. S. Logan, et al.
The role of antibodies in dysfunction of pig-to-baboon pulmonary transplants
J. Thorac. Cardiovasc. Surg., July 1, 2000; 120(1): 29 - 38.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
D. M. Kulick, C. T. Salerno, A. P. Dalmasso, S. J. Park, M. G. Paz, W. L. Fodor, and R. M. Bolman III
TRANSGENIC SWINE LUNGS EXPRESSING HUMAN CD59 ARE PROTECTED FROM INJURY IN A PIG-TO-HUMAN MODEL OF XENOTRANSPLANTATION
J. Thorac. Cardiovasc. Surg., April 1, 2000; 119(4): 690 - 699.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
P. Macchiarini, R. Oriol, A. Azimzadeh, V. de Montpreville, P. Wolf, and P. Dartevelle
CHARACTERIZATION OF A PIG-TO-GOAT ORTHOTOPIC LUNG XENOTRANSPLANTATIONMODEL TO STUDY BEYOND HYPERACUTE REJECTION
J. Thorac. Cardiovasc. Surg., November 1, 1999; 118(5): 805 - 814.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Macchiarini, P
Right arrow Articles by Dartevelle, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Macchiarini, P
Right arrow Articles by Dartevelle, P

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS